correspondence

ACMD advice on the classification and schedule of Remimazolam

Published 2022-12-02.

Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam.

§ Publishing organisations

Departments and bodies that published this